A SIMPLE ISOCRATIC ION-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE 5'-TRIPHOSPHATE FOR INTRACELLULAR DRUG-MONITORING AND INVITRO INCUBATION ASSAYS

被引:8
作者
BOOS, J
机构
[1] Department of Pediatrics, University of Münster
关键词
ARABINOFURANOSYLCYTOSINE-TRIPHOSPHATE; LEUKEMIA; INTRACELLULAR DRUG MONITORING; CYTARABINE METABOLISM;
D O I
10.1016/0731-7085(91)80236-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A sensitive isocratic ion-pair HPLC method using a reversed-phase C18 column and phosphate buffer at pH 6 for the determination of the cytotoxic intracellular anabolite 1-beta-D-arabinofuranosylcytosine-triphosphate (Ara-CTP) of the antineoplastic drug cytarabine in leukaemic cells in vivo is described. Simultaneous determination of the physiological nucleotide deoxycytidine-triphosphate is possible. The recovery from cells is > 90%, the limit of detection is 25 ng ml-1 (51 nM l-1) and about 10 pM mg-1 cell protein. Extraction procedure and pitfalls are discussed. The method enables intracellular drug monitoring of Ara-CTP with standard HPLC equipment.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 39 条
[1]  
AVRAMIS VI, 1989, CANCER RES, V49, P241
[2]  
AVRAMIS VI, 1987, CANCER RES, V47, P6786
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
BREITHAUPT H, 1982, CANCER, V50, P1248, DOI 10.1002/1097-0142(19821001)50:7<1248::AID-CNCR2820500705>3.0.CO
[5]  
2-5
[6]   SYNERGY BETWEEN HIGH-DOSE CYTARABINE AND ASPARAGINASE IN THE TREATMENT OF ADULTS WITH REFRACTORY AND RELAPSED ACUTE MYELOGENOUS LEUKEMIA - A CANCER AND LEUKEMIA GROUP-B STUDY [J].
CAPIZZI, RL ;
DAVIS, R ;
POWELL, B ;
CUTTNER, J ;
ELLISON, RR ;
COOPER, MR ;
DILLMAN, R ;
MAJOR, WB ;
DUPRE, E ;
MCINTYRE, OR .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :499-508
[7]   ALTERATION OF THE PHARMACOKINETICS OF HIGH-DOSE ARA-C BY ITS METABOLITE, HIGH ARA-U IN PATIENTS WITH ACUTE-LEUKEMIA [J].
CAPIZZI, RL ;
YANG, JL ;
CHENG, E ;
BJORNSSON, T ;
SAHASRABUDHE, D ;
TAN, RS ;
CHENG, YC .
JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) :763-771
[8]  
CHENG YC, 1971, BIOCHEMISTRY-US, V10, P2139
[9]  
DOW LW, 1986, BLOOD, V68, P400
[10]  
EARLY AP, 1982, CANCER RES, V42, P1587